Lv6
3070 积分 2021-05-31 加入
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough
28天前
已完结
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus Erythematosus
1个月前
已完结
Ruxolitinib cream for discoid lupus erythematosus: An open-label pilot study of 10 subjects
1个月前
已完结
Baricitinib for SLE: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
1个月前
已完结
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
1个月前
已完结
Case Report: Daratumumab for a Patient With Refractory Systemic Lupus Erythematosus and Antiphospholipid Syndrome Presenting as Thrombocytopenia
1个月前
已完结
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study
1个月前
已完结
Iptacopan/LNP023 and rituximab as rescue therapy in a patient with systemic lupus erythematosus-associated atypical haemolytic uraemic syndrome
1个月前
已完结
Systemic lupus erythematosus presenting with atypical hemolytic uremic syndrome: a case report and review of the literature
1个月前
已完结
皖公网安备34019202002308
